156 related articles for article (PubMed ID: 33441543)
1. Overcoming hypoxia-induced resistance of pancreatic and lung tumor cells by disrupting the PERK-NRF2-HIF-axis.
Küper A; Baumann J; Göpelt K; Baumann M; Sänger C; Metzen E; Kranz P; Brockmeier U
Cell Death Dis; 2021 Jan; 12(1):82. PubMed ID: 33441543
[TBL] [Abstract][Full Text] [Related]
2. Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2.
Al Taleb Z; Petry A; Chi TF; Mennerich D; Görlach A; Dimova EY; Kietzmann T
J Mol Med (Berl); 2016 Oct; 94(10):1153-1166. PubMed ID: 27286880
[TBL] [Abstract][Full Text] [Related]
3. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells.
Malec V; Gottschald OR; Li S; Rose F; Seeger W; Hänze J
Free Radic Biol Med; 2010 Jun; 48(12):1626-35. PubMed ID: 20347035
[TBL] [Abstract][Full Text] [Related]
4. TGF-β and Hypoxia/Reoxygenation Promote Radioresistance of A549 Lung Cancer Cells through Activation of Nrf2 and EGFR.
Lee SL; Ryu H; Son AR; Seo B; Kim J; Jung SY; Song JY; Hwang SG; Ahn J
Oxid Med Cell Longev; 2016; 2016():6823471. PubMed ID: 26904167
[TBL] [Abstract][Full Text] [Related]
5. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.
Kim TH; Hur EG; Kang SJ; Kim JA; Thapa D; Lee YM; Ku SK; Jung Y; Kwak MK
Cancer Res; 2011 Mar; 71(6):2260-75. PubMed ID: 21278237
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute hypoxia exposure with different durations on activation of Nrf2-ARE pathway in mouse skeletal muscle.
Ji W; Wang L; He S; Yan L; Li T; Wang J; Kong AT; Yu S; Zhang Y
PLoS One; 2018; 13(12):e0208474. PubMed ID: 30513114
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide inhibits hypoxia-induced HIF-1α-driven endothelin 1 secretion by activating Nrf2/HO-1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells.
Lin HC; Su SL; Lu CY; Lin AH; Lin WC; Liu CS; Yang YC; Wang HM; Lii CK; Chen HW
Environ Toxicol; 2017 Mar; 32(3):918-930. PubMed ID: 27297870
[TBL] [Abstract][Full Text] [Related]
8. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
9. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.
Ji X; Wang H; Zhu J; Zhu L; Pan H; Li W; Zhou Y; Cong Z; Yan F; Chen S
Int J Cancer; 2014 Aug; 135(3):574-84. PubMed ID: 24374745
[TBL] [Abstract][Full Text] [Related]
11. Enhancer-bound Nrf2 licenses HIF-1α transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells.
Jin X; Gong L; Peng Y; Li L; Liu G
Aging (Albany NY); 2020 Dec; 13(1):364-375. PubMed ID: 33290263
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 promotes breast cancer cell migration via up-regulation of G6PD/HIF-1α/Notch1 axis.
Zhang HS; Zhang ZG; Du GY; Sun HL; Liu HY; Zhou Z; Gou XM; Wu XH; Yu XY; Huang YH
J Cell Mol Med; 2019 May; 23(5):3451-3463. PubMed ID: 30809937
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rb3 protects cardiomyocytes against hypoxia/reoxygenation injury via activating the antioxidation signaling pathway of PERK/Nrf2/HMOX1.
Sun J; Yu X; Huangpu H; Yao F
Biomed Pharmacother; 2019 Jan; 109():254-261. PubMed ID: 30396083
[TBL] [Abstract][Full Text] [Related]
15. Myofibrillogenesis regulator-1 attenuated hypoxia/reoxygenation-induced apoptosis by inhibiting the PERK/Nrf2 pathway in neonatal rat cardiomyocytes.
Tao TQ; Wang XR; Liu M; Xu FF; Liu XH
Apoptosis; 2015 Mar; 20(3):285-97. PubMed ID: 25542256
[TBL] [Abstract][Full Text] [Related]
16. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
17. LB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling.
Niu F; Li Y; Lai FF; Ni L; Ji M; Jin J; Yang HZ; Wang C; Zhang DM; Chen XG
J Cell Physiol; 2015 Sep; 230(9):2212-23. PubMed ID: 25655308
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
Yang KQ; Liu Y; Huang QH; Mo N; Zhang QY; Meng QG; Cheng JW
BMC Cancer; 2017 Dec; 17(1):878. PubMed ID: 29268703
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes.
Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
Toxicol Sci; 2017 Feb; 155(2):432-443. PubMed ID: 27837167
[TBL] [Abstract][Full Text] [Related]
20. Berberine ameliorates lipopolysaccharide-induced acute lung injury via the PERK-mediated Nrf2/HO-1 signaling axis.
Liang Y; Fan C; Yan X; Lu X; Jiang H; Di S; Ma Z; Feng Y; Zhang Z; Feng P; Feng X; Feng J; Jin F
Phytother Res; 2019 Jan; 33(1):130-148. PubMed ID: 30346043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]